COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: AENA, ENCE, INDRA, ROVI VIDRALA. EUROPA: N/A. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 4T’25 que se publicarán en España y Europa en los próximos días. Europa no capitaliza el rebote Mayor estabilidad en las bolsas europeas, a pesar del rebote en las empresas de software estadounidenses como consecuen...
NEWS SUMMARY: AENA, ENCE, INDRA, ROVI, VIDRALA. At the end of today’s report, and during the entire results season, we will include a presentation with positive and negative results highlights and previews for the 4Q’25 results to be released over the coming days in Spain. Europe unable to capitalise on the rally European stock markets found greater stability, despite the rally by US software companies as a result of the overselling due to fears of a disruption brought about by AI. In the STOX...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: CAF, ENCE, ENDESA, METROVACESA, TELEFÓNICA. EUROPA: N/A. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 4T’25 que se publicarán en España y Europa en los próximos días. El Ibex se desmarca en positivo Los índices europeos mostraron una reacción mixta a las nuevas amenazas proteccionistas de Trump (mejor p...
NEWS SUMMARY: CAF, ENCE, ENDESA, METROVACESA, TELEFÓNICA. At the end of today’s report, and during the entire results season, we will include a presentation with positive and negative results highlights and previews for the 4Q’25 results to be released over the coming days in Spain. IBEX the one positive note European stock markets showed a mixed reaction to Trump’s new protectionist measures (the periphery outperformed core countries), while companies exposed to the disruption from AI continu...
Barco's FY25 results were broadly in line with market expectations, demonstrating the company's ability to grow sales and margins despite a challenging macro environment. However, the performance also revealed vulnerabilities—most notably a significant decline in order intake and a sharp reduction in the order book, both of which signal weakening forward demand and warrant close attention. Cinema was the strongest division, while Healthcare underperformed. EBITDA slightly exceeded expectations,...
The announcement in early February of the new medium-term strategic plan (2026-2029) bolstered our Outperform rating on ISP (TP raised to € 7.0 from € 6.4), one of our sector top picks. In short, when the strategy is right, continuity has its virtues! Although ISP is lagging behind the sector in terms of re-rating, its valuation remains attractive given its fundamentals and outlook (RoE +4pp to 18% by 2029e, total return of 12% vs 6% for the sector).
L’annonce, début février, du nouveau plan stratégique MT (2026-29) a renforcé notre opinion Surperformance sur ISP (OC porté à 7.0 € vs 6.4 €), l’un de nos top picks sectoriels. En un mot, quand une stratégie est bonne, la continuité a des vertus ! Alors qu’ISP est à la traîne en termes de rerating vs secteur, la valorisation reste intéressante au regard des fondamentaux et des perspectives (RoE +4pp à 18% d’ici 2029e, total return de 12% vs 6% pour secteur).
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.